This is a demo store. No orders will be fulfilled.

Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Vital Signs - Healthcare News - The Analysts Perspective - June 2014

Vital Signs - Healthcare News - The Analysts Perspective - June 2014

RELEASE DATE
01-Jul-2014
REGION
Global
Deliverable Type
Market Research
Research Code: 9A35-00-1A-00-00
SKU: LS00197-GL-MR_17427
$450.00
In stock
SKU
LS00197-GL-MR_17427
$450.00
DownloadLink
Add to Compare

Pay by invoice

ENQUIRE NOW

Description

This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogen's Eloctate, Qiagen's acquisition of Primera Dx, Roche's acquisition of Genia Technologies, Cue's at-home connected lab test, and the Credihealth Teen Clinic.

Table of Contents

This week's issue

Request Sample
Popular Topics

probiotics market

offshore market

thermostat market

wearable technology market

fleet management market

biometric authentication market

dietary supplements market

packaged food industry

surfactants market

vaccine market

This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.
More Information
Deliverable Types Market Research
No Index Yes
Podcast No
Author Jennifer Lazar
WIP Number 9A35-00-1A-00-00
Is Prebook No